Efficacy and safety of saxagliptin 5 mg once-daily therapy in elderly patients with type 2 diabetes mellitus

被引：0
|
作者：
Maheux, P. [1 ]
Doucet, J. [2 ]
Allen, E. [3 ]
Ravichandran, S. [3 ]
Harris, S.
Chen, R. [3 ]
Brulle, C. [4 ]
机构：
[1] AstraZeneca ISMO Europe, Brussels, Belgium
[2] CHU Rouen, Rouen, France
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb EMEA, Paris, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [21] Once-daily glimepiride in type 2 diabetes mellitus: Possible tolerability advantages
    不详
    Drugs & Therapy Perspectives, 1998, 12 (2) : 1 - 5
  • [22] Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on sulfonylurea ± metformin (GetGoal-S)
    Ratner, R. E.
    Hanefeld, M.
    Shamanna, P.
    Min, K.
    Boka, G.
    Miossec, P.
    Muehlen-Bartmer, I.
    Rosenstock, J.
    DIABETOLOGIA, 2011, 54 : S317 - S317
  • [23] Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on metformin (GetGoal-F1)
    Bolli, G.
    Munteanu, M.
    Dotsenko, S.
    Niemoeller, E.
    Boka, G.
    Hanefeld, M.
    DIABETOLOGIA, 2011, 54 : S316 - S317
  • [24] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Yolanda
    Zhao, June
    Pan, Changyu
    DIABETES, 2017, 66 : A327 - A327
  • [25] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [26] Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy
    Bryzinski, Brian
    Allen, Elsie
    Cook, William
    Hirshberg, Boaz
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 887 - 893
  • [27] Long-term safety and efficacy of antihypertensive therapy with valsartan 320 mg once-daily
    Asmar, R.
    Mengden, T.
    Brudi, P.
    Kandra, A.
    Di Giovanni, R.
    Parati, G.
    JOURNAL OF HYPERTENSION, 2006, 24 : S19 - S20
  • [28] Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
    Xue, Mei
    Shen, Pan
    Tang, Jun
    Deng, Xuan
    Dai, Zhe
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [29] Comparison of efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetes patients with erectile dysfunction
    Park, K. -S.
    Park, S.
    Lee, J.
    Cha, B.
    Park, S.
    Min, K.
    Sung, Y.
    Kim, T.
    Park, I.
    Moon, H.
    DIABETOLOGIA, 2012, 55 : S478 - S479
  • [30] Comparison of Efficacy and Safety of Once-Daily Dosing and On-Demand Use of Udenafil for Type 2 Diabetes Patients with Erectile Dysfunction
    Yu, Hea Min
    Ryu, Ah Jeong
    Park, Soon Hyun
    Park, Sung Woo
    Cha, Bong Yun
    Park, Ie Byung
    Min, Kyung Wan
    Sung, Yeon Ah
    Kim, Tae Hwa
    Lee, Jae Min
    Park, Kang Seo
    DIABETES, 2014, 63 : A294 - A294
12345